COVID-19-Associated Acute Psychotic Disorder-Longitudinal Case Report and Brief Review of Literature.
Maria Gabriela PuiuVlad DionisieAndra Ioana DobrinMirela ManeaPublished in: Medicina (Kaunas, Lithuania) (2023)
Even though since the beginning of the COVID-19 pandemic, the literature became more and more abundant on data and hypotheses about the various consequences on people's lives, more clarity needs to be added to the existing information. Besides the stressful experiences related to the COVID-19 pandemic, SARS-CoV-2 infection has been proven to impact brain functioning through direct and indirect pathogenic mechanisms. In this context, we report a case of a patient presenting with a first episode of psychosis following COVID-19. In our case, a 28-year-old male patient with no personal or family psychiatric history developed psychotic symptoms (delusions, hallucinations, and disorganized behaviour) that required antipsychotic treatment and inpatient hospitalization one week after he was discharged from the hospital after COVID-19. At the six-month and one-year follow-up, the patient was in remission without any psychotic signs or symptoms. A brief review of the literature is also provided. The case presented in this article outlines the possibility that the post-COVD-19 recovery period might be a crucial time for the onset of acute psychotic disorder, and therefore, routine psychiatric assessments should be carried out during all phases of the disease. A clearer picture of the impact of the COVID-19 pandemic on mental health will most likely be revealed in the future as many consequences need long-term evaluation.
Keyphrases
- mental health
- coronavirus disease
- bipolar disorder
- sars cov
- case report
- liver failure
- respiratory failure
- systematic review
- drug induced
- mental illness
- aortic dissection
- clinical practice
- electronic health record
- clinical trial
- rheumatoid arthritis
- big data
- depressive symptoms
- physical activity
- brain injury
- sleep quality
- current status
- intensive care unit
- functional connectivity
- combination therapy
- adverse drug
- study protocol